At the 8th China International Import Expo (CIIE), Foshan Chancheng Hospital (hereinafter "Foshan Chancheng Hospital") signed a strategic cooperation agreement with SciClone Pharmaceuticals, deepening the clinical application of the oral SERD (Selective Estrogen Receptor Degrader) drug, Elacestrant, for treating advanced breast cancer. As the first designated medical institution in Foshan under the "Greater Bay Area Drug and Medical Device Connect" policy, this oral medicatio